Skip to main content
On this page

    A medicines formulary is an agreed list of medicines and their approved indications and restrictions. 

    The formulary will establish a statewide approach to medicines governance and a single evidence-based list of medicines for use in Victorian public hospitals and health services. 

    This formulary aims to: 

    • improve the safety and quality use of medicines 
    • support more equitable access to medicines 
    • reduce unnecessary variation in prescribing and medicines use 
    • strengthen statewide medicines governance and coordination across Victoria.

    Why the formulary is important 

    A statewide medicines formulary will support safer and more consistent use of medicines and more equitable access to evidence-based treatment across Victoria.

    Victoria is currently the only Australian jurisdiction without a statewide medicines formulary. Different public hospitals and health services use different approved medicines lists, which can lead to variation in medicine access and care across the state.

    How the formulary is being developed

    Progress to date

    Since 2025, we have been establishing the foundations for a statewide formulary. 

    Work to date includes: 

    • analysing existing health service formularies and medicines governance arrangements to inform the build and implementation of the formulary 
    • establishing cross-departmental governance to ensure coordinated support for formulary establishment 
    • developing the policy and governance foundations for the formulary 
    • formalising the partnership between Safer Care Victoria and HealthShare Victoria 
    • engaging with metropolitan, regional and rural health services to inform the design and implementation of the formulary 
    • progressing procurement of a statewide digital solution to manage and share formulary information.

    For regular news and updates, please see the Latest news | Victorian Medicines Formulary.

    Where we are now

    The formulary has moved from early planning and design into development and preparation for implementation. 

    Work ahead includes: 

    • developing the baseline formulary medicines list and how medicines will be assessed for inclusion 
    • establishing the formulary’s clinical governance bodies  
    • procuring and developing the digital solution that will manage and share formulary information  
    • working with public health services and clinicians to inform the design and implementation of the formulary 
    • preparing the support health services will need as the formulary is introduced.

    Developing and introducing the formulary in stages

    The formulary will be developed and introduced in stages, with medicines reviewed in a series of clinical tranches.

    With each tranche, we will work with clinical experts and health services to develop the formulary and prepare for implementation.

    The first tranche will be cardiovascular medicines, as the pilot tranche to test and refine formulary implementation processes.

    This staged approach allows the processes and support for implementation to be tested and refined as the formulary is introduced.

    The clinical areas for tranches 2-5 are proposed and may be refined based on expert advice, consultation and system readiness. each tranche will inform the approach to later stages.


    Clinical tranches

    1. Tranche 1

      Commences 2027
      • Cardiovascular medicines
    2. Tranches 2-5

      From 2027
      • Respiratory medicines
      • Systemic hormones
      • Endocrinology
      • Nervous system
      • Musculoskeletal system
      • Dermatological
      • Alimentary tract
      • Antineoplastic and immunomodulating agents
      • Anti-infectives
      • Sensory organs

    Stages of development

    1. 1. Develop

      Review medicines and establish listings.
    2. 2. Prepare

      Plan for implementation and support health services.
    3. 3. Implement

      Introduce tranches and support adoption.
    4. 4. Learn and refine

      Monitor, evaluate and apply learnings.

     


    Engagement and consultation

    Input from Victoria's public health services and clinicians is helping shape the formulary. 

    During 2026, we engaged with metropolitan, regional and rural health services.

    Engagement will continue as the formulary is developed. Health services, clinicians and subject matter experts will have opportunities to contribute to relevant areas of work.

    What we heard

    Community engagement

    Patient, carer and community perspectives are important to understanding people’s experiences of accessing and using medicines. 

    These perspectives will continue to inform the development and implementation of the formulary, including through consumer representation on the Clinical Council. 

    We will provide more information about how patients, carers and the community can contribute as this work progresses. 

    Frequently asked questions

    The formulary is intended for Victorian public health services established under the Health Services Act 1988 including public hospitals, denominational hospitals, public health services and multipurpose services.

    No. Having a medicine on the formulary does not mean every health service must stock or use it.

    Health services will continue to consider their local service capability, clinical expertise, patient needs and models of care when deciding which formulary medicines they stock.

    Existing local formularies will remain the source of information for clinicians while the statewide formulary is progressively developed and introduced. 

    As each tranche is completed, health services will transition relevant parts of their local formularies to reflect the statewide formulary.

    The Clinical Council will consider evidence and expert advice when making recommendations about medicines for the formulary. 

    Considerations include clinical effectiveness, safety, equity of access, implementation and health system impacts, and value.

    The initial focus is on establishing a central digital source for formulary information. 

    Future connections with electronic medical records and other clinical systems will need to take account of the different digital systems used across Victorian public health services.

    Learn more

    Governance and clinical leadership

    Learn how the formulary will be supported by statewide clinical governance that brings together expertise from across Victoria's public health system.

    Learn more
    Was this content helpful to you?